Form 6-K NEOVASC INC For: Dec 02

Go back to Form 6-K NEOVASC INC For: Dec 02

Leerink Reaffirms Neovasc (NVCN) at 'Outperform' Amid Boston Scientific Deal

December 2, 2016 11:57 AM EST

Leerink affirms Neovasc Inc. (Nasdaq: NVCN) at Outperform with a price target of $10 following news of an asset sales agreement with Boston Scientific... More